Registry for severe, uncontrolled chronic sinusitis in Italy
Part of Ear, nose & throat, Infections, Lungs & breathing clinical trials.
This trial is a registry that enrolls people with severe, hard-to-control chronic sinusitis. It helps doctors better understand this specific type of inflammation and how it affects symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic sinusitis in both sides (bilateral).
- Your case shows a type of body inflammation called “type 2,” such as high eosinophils or specific immune test results.
- Your symptoms have required repeated steroid tablets/syrups (at least two short courses or long-term use).
- Your quality of life is significantly worse (SNOT-22 score 40+ and/or symptom VAS 5+).
- You have notable loss of smell (hyposmia VAS 7+).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a nebulizer to deliver steroid spray can help people with chronic sinusitis (CRS) without prior sinus surgery. It focuses on improving symptoms like nasal congestion and facial pressure.
This study collects information from people with severe asthma across Italy to better understand the condition and improve treatment. By joining, you help researchers learn what works best for people like you.
This study is a registry that tracks how well treatments work for people with chronic rhinosinusitis with nasal polyps. By joining, you help doctors learn which therapies lead to better control and possibly remission of symptoms over time.
This study tests a new sinus stent that slowly releases medicine to treat chronic sinusitis in both nostrils. The goal is to see if it helps reduce symptoms and inflammation better than usual care.
This trial tests if seeing a lung specialist and an ear-nose-throat doctor together in one visit helps people with asthma and chronic sinusitis (with nasal polyps) feel better than seeing each specialist separately. You may qualify if your asthma or sinusitis is not well-controlled and you've used steroid pills in the past year.
This trial tests a new antibody medicine (CM326) for people with chronic sinusitis and nasal polyps whose symptoms persist despite standard treatments like nasal sprays. It aims to see if the drug can reduce inflammation and improve symptoms.
Hear when a new Chronic Rhinosinusitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.